Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Anemia, Refractory, with Excess of Blasts × Transplantation × 1 year × Clear all

Sponsor

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Multiple Myeloma 2 Leukemia, Myeloid, Acute 2 Thrombocytopenia 1 Sarcoma, Myeloid 1 Recurrence 1 Neutropenia 1 Neoplasms, Plasma Cell 1 Neoplasm, Residual 1 Myelodysplastic Syndromes 1 Lymphopenia 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Large B-Cell, Diffuse 1 Leukemia, Myelomonocytic, Juvenile 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 High Risk Hematologic Malignancy 1 Hepatoblastoma 1 Hematologic Neoplasms 1 Dupuytren Contracture 1 Congenital Abnormalities 1 Anemia 1

Interventions

Cyclophosphamide 15 fludarabine phosphate 12 Whole-Body Irradiation 12 Mycophenolic Acid 12 fludarabine 11 Tacrolimus 8 Peripheral Blood Stem Cell Transplantation 8 Busulfan 8 Melphalan 7 Granulocyte Colony-Stimulating Factor 5 Cyclosporine 5 Azacitidine 5 Filgrastim 4 venetoclax 3 Cord Blood Stem Cell Transplantation 3 Biopsy 3 thymoglobulin 2 decitabine and cedazuridine drug combination 2 Vorinostat 2 Thiotepa 2 Specimen Handling 2 Sirolimus 2 Rituximab 2 Methotrexate 2 Hematopoietic Stem Cell Transplantation 2 Etoposide 2 Cyclosporins 2 Clofarabine 2 Bone Marrow Transplantation 2 treosulfan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡